Cargando…
Study protocol for SFX-01 after subarachnoid haemorrhage (SAS): a multicentre randomised double-blinded, placebo controlled trial
INTRODUCTION: Subarachnoid haemorrhage (SAH) from a ruptured cerebral aneurysm carries high morbidity and mortality. Despite huge advances in techniques to secure the aneurysm, there has been little progress in the treatment of the deleterious effects of the haemorrhage. Sulforaphane is an Nrf2 indu...
Autores principales: | Zolnourian, Ardalan H, Franklin, Stephen, Galea, Ian, Bulters, Diederik Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170552/ https://www.ncbi.nlm.nih.gov/pubmed/32217557 http://dx.doi.org/10.1136/bmjopen-2018-028514 |
Ejemplares similares
-
Neuroprotective Role of the Nrf2 Pathway in Subarachnoid Haemorrhage and Its Therapeutic Potential
por: Zolnourian, Ardalan, et al.
Publicado: (2019) -
Neurofilament light predicts neurological outcome after subarachnoid haemorrhage
por: Garland, Patrick, et al.
Publicado: (2021) -
Long‐term fatigue following aneurysmal subarachnoid haemorrhage and the impact on employment
por: Gaastra, Ben, et al.
Publicado: (2022) -
Haptoglobin Genotype and Outcome after Subarachnoid Haemorrhage: New Insights from a Meta-Analysis
por: Gaastra, Ben, et al.
Publicado: (2017) -
Corrigendum to “Haptoglobin Genotype and Outcome after Subarachnoid Haemorrhage: New Insights from a Meta-Analysis”
por: Gaastra, Ben, et al.
Publicado: (2018)